IRIX vs. RMTI, CUTR, PHUN, DFLI, REFR, KTCC, CMTL, MATH, NSYS, and PODC
Should you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Rockwell Medical (RMTI), Cutera (CUTR), Phunware (PHUN), Dragonfly Energy (DFLI), Research Frontiers (REFR), Key Tronic (KTCC), Comtech Telecommunications (CMTL), Metalpha Technology (MATH), Nortech Systems (NSYS), and PodcastOne (PODC).
Rockwell Medical (NASDAQ:RMTI) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.
Rockwell Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.
Rockwell Medical has a net margin of -10.09% compared to Rockwell Medical's net margin of -18.45%. IRIDEX's return on equity of -39.17% beat Rockwell Medical's return on equity.
23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 2.2% of Rockwell Medical shares are held by insiders. Comparatively, 6.2% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Rockwell Medical received 29 more outperform votes than IRIDEX when rated by MarketBeat users. However, 69.92% of users gave IRIDEX an outperform vote while only 57.33% of users gave Rockwell Medical an outperform vote.
Rockwell Medical has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Rockwell Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, IRIDEX had 1 more articles in the media than Rockwell Medical. MarketBeat recorded 2 mentions for IRIDEX and 1 mentions for Rockwell Medical. IRIDEX's average media sentiment score of 0.00 equaled Rockwell Medical'saverage media sentiment score.
Rockwell Medical presently has a consensus price target of $7.00, suggesting a potential upside of 381.10%. IRIDEX has a consensus price target of $2.00, suggesting a potential downside of 30.31%. Given IRIDEX's higher probable upside, equities research analysts plainly believe Rockwell Medical is more favorable than IRIDEX.
Summary
Rockwell Medical beats IRIDEX on 12 of the 16 factors compared between the two stocks.
Get IRIDEX News Delivered to You Automatically
Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
